Prashant Kumar

Prashant Kumar (Singapore) joined KKR in 2018 and is a Partner. He is the head of the South-East Asia Private Equity team. Mr. Kumar has led a number of the firm’s investments, including Max Healthcare, JB Chemicals & Pharmaceuticals, Vini Cosmetics, and Advanta India. Prior to joining KKR, Mr. Kumar was a director and member of the investment committee at ChrysCapital, a leading India-focused private equity fund. Previously, he was with Warburg Pincus where led investments in various sectors. Prior to that, Mr. Kumar worked at Karsch Capital Management, a New York-based hedge fund, and SUN Capital, an emerging markets focused private equity firm. He began his career as a consultant with McKinsey & Company. Mr. Kumar holds a B.Tech. from the Indian Institute of Technology Delhi, a post-graduate diploma in management from the Indian Institute of Management Kolkata, and an M.B.A. from The Wharton School at the University of Pennsylvania.